English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

UPL obtains all regulatory approvals for Arysta LifeScience acquisitionqrcode

Jan. 28, 2019

Favorites Print
Forward
Jan. 28, 2019
UPL, in a press note to the exchanges, informed that the company has obtained all regulatory approvals for the acquisition of 100% stake of Arysta LifeScience.
 
Accordingly, the company is expected to complete the transaction with regards to acquisition by January 31, 2019, said UPL in a press release after market hours to the exchanges last Thursday.
Source: IIFL

0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe India Special Biweekly to send news related to your mailbox